Skip to main content
Clinical Trials/NCT03044704
NCT03044704
Active, Not Recruiting
N/A

Influence of Haemodynamic and Geometric Factors on the Onset and Progression of Atherosclerosis

Medical University Innsbruck1 site in 1 country100 target enrollmentFebruary 6, 2017
ConditionsAtherosclerosis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Atherosclerosis
Sponsor
Medical University Innsbruck
Enrollment
100
Locations
1
Primary Endpoint
Correlation between geometrical and hemodynamic parameters and the progression of atherosclerosis
Status
Active, Not Recruiting
Last Updated
4 years ago

Overview

Brief Summary

The study is a prospective-observational, explorative single-centre cohort study aimed to examine the influence of hemodynamic and geometric parameters on the progression of atherosclerotic alterations in peripheral vessels (carotids, femoral artery). Atherosclerotic alterations (IMT, plaque volume) will be measured with a ultrasound (IMT measurements and 3D quantitative plaque volumetry) and magnetic resonance imaging (MRI). Geometric parameters (e.g. carotid/femoral bifurcation angle, carotid/femoral bifurcation area) are assessed with magnetic resonance imaging (MRI) and also 3D ultrasonography.

A total of 100 patients with an asymmetrical plaque distribution in carotid and femoral arteries will be tested. Only patients who are already enrolled in the "Correlation of Artherosclerotic Plaque Volume and Intima Media Thickness With Soluble P-selectin" (NCT01895725) and who are tested prior for an asymmetrical plaque distribution will be included in this study. MRI will be performed once whereas ultrasound imaging will be be repeated once per year (up to five times) to assess changes in these parameters over time. Also plasma samples will be collected once yearly and tested for traditional and novel cardiovascular risk factors.

The primary endpoint of the planned study will be the correlation between geometrical and hemodynamic parameters as stated above and the progression of atherosclerosis as measured by plaque volume and IMT in the carotid and femoral arteries, respectively.

Secondary endpoints will include the correlation of geometrical and hemodynamic parameters with established (hypertension, smoking, diabetes, dyslipidemia) and novel risk factors (hsCRP, P-selectin, cholesteryl ester transfer protein (CETP), intercellular adhesion molecule-1 (ICAM-1), CETP TaqIb polymorphism), with cardiovascular event rate, plaque localization, plaque morphology and the additional predictive value of geometrical parameters compared to an established risk score (SCORE card).

Registry
clinicaltrials.gov
Start Date
February 6, 2017
End Date
January 2028
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Medical University Innsbruck
Responsible Party
Principal Investigator
Principal Investigator

Peter Marschang

Ao. Univ.Prof.Dr.

Medical University Innsbruck

Eligibility Criteria

Inclusion Criteria

  • asymmetrical (side difference) plaque distribution in carotids/femoral arteries which was tested in at least two prior 3D-ultrasound examinations (absolute side difference in carotid arteries ≥ 30 mm3 or in femoral arteries ≥50 mm3 and relative side difference in carotid arteries/femoral arteries ≥50% )

Exclusion Criteria

  • actual pregnancy, lactation period, chronic renal insufficiency (GFR\<20ml/min)

Outcomes

Primary Outcomes

Correlation between geometrical and hemodynamic parameters and the progression of atherosclerosis

Time Frame: up to 1 year

Haemodynamic/geometric parameters will be assessed with MRI and 3D-US. This includes carotid/femoral bifurcation angle, common carotid/femoral area, carotid/femoral bifurcation area, internal and external carotid area, femoral superficial artery area and carotid/femoral bifurcation length. Progression of atherosclerosis will be measured via 3D-US by plaque volume and IMT in the carotid and femoral arteries, respectively.

Secondary Outcomes

  • Correlation of geometrical and hemodynamic parameters with established and novel risk factors.(up to 1 year)
  • Correlation of geometrical and hemodynamic parameters with cardiovascular event rate(1 year)
  • Correlation of geometrical and hemodynamic parameters with plaque morphology(up to 1 year)

Study Sites (1)

Loading locations...

Similar Trials